Therefore, using the cells from the patients with progressive chronic HCV infection developing hepatocellular carcinoma or diffuse large B cell lymphomas could better mimic the SHP-1 methylation status seen in Jurkat cells. This evidence concerns the gene NR0B2 and diffuse large B-cell lymphoma.